APA (7th ed.) Citation

Gaiser, T., Sauer, C., Marx, A., Jakob, J., Kasper, B., Hohenberger, P., . . . Ronellenfitsch, U. (2021). Molecular and Pathological Profiling of Corresponding Treatment-Naïve and Neoadjuvant Pazopanib-Treated High-Risk Soft Tissue Sarcoma Samples of the GISG-04/NOPASS Study. Biology (2079-7737), 10(7), 639. https://doi.org/10.3390/biology10070639

Chicago Style (17th ed.) Citation

Gaiser, Timo, Christian Sauer, Alexander Marx, Jens Jakob, Bernd Kasper, Peter Hohenberger, Daniela Hirsch, and Ulrich Ronellenfitsch. "Molecular and Pathological Profiling of Corresponding Treatment-Naïve and Neoadjuvant Pazopanib-Treated High-Risk Soft Tissue Sarcoma Samples of the GISG-04/NOPASS Study." Biology (2079-7737) 10, no. 7 (2021): 639. https://doi.org/10.3390/biology10070639.

MLA (9th ed.) Citation

Gaiser, Timo, et al. "Molecular and Pathological Profiling of Corresponding Treatment-Naïve and Neoadjuvant Pazopanib-Treated High-Risk Soft Tissue Sarcoma Samples of the GISG-04/NOPASS Study." Biology (2079-7737), vol. 10, no. 7, 2021, p. 639, https://doi.org/10.3390/biology10070639.